Meningococcal B Vaccination Implementing the ACIP Category B Recommendations.

Slides:

Advertisements

Similar presentations

Karen Broder, M.D. Epidemic Intelligence Service Officer

Advertisements

Contents  Describe epidemiology of meningococcal serogroups C disease  What, why and when are the changes happening  Which vaccines are recommended?

An Approach to Demonstration of Effectiveness

ACIP Meeting Update November 4 th

Adult Immunization 2010 Meningococcal Vaccine Segment This material is in the public domain This information is valid as of May 25, 2010.

1 Universal Immunization Against Rare Diseases  How much is a child’s life worth?  The individual vs society.

Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.

Central Nervous System Infections. RABIES.

State Affiliate Challenge 1 South Dakota School Nurses Association Florida Association of School Nurses Delaware School Nurse Association.

American Academy of Pediatrics, Committee on Infectious Diseases. Policy Updated Recommendations on the Use of Meningococcal Vaccines Pediatrics. doi:

Kindergarten Considerations and Timeline to Incorporate a New Vaccine in City and State Immunization Programs in the United States Katelyn Wells MS, Association.

What is meningococcal disease?  Adolescents and young adults are at increased risk of meningococcal disease, often referred to as meningitis, a serious.

Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010 Koh Cheng Thoon, Chia Yin Chong,

Ann Intern Med. 2007;147(10): doi: / Figure Legend:

MenACWY – new immunisation programme? What’s new?

Changes to the 2016 Childhood and Adolescent Immunization Schedule

US Burden of Disease and Injury Study, 1996

You are the Key to HPV Cancer Prevention

The Changing Epidemiology of Acute Hepatitis A in Texas

The Importance of Numbers

Meningococcal Conjugate Vaccine Failures in the United States

General guide for assessing immunizations among refugees

Table 4. Effect of vaccination status on serogroup C serum bactericidal antibody (SBA) titers, IgG levels, and avidity indices (AIs) in acute and convalescent.

Epidemiology Section APHA Tuesday, Nov. 6, 2007

Influenza Immunization:

Back to School 2013: An Immunization Checklist

Adolescent Immunization Update

An Update on Meningococcal Disease Dr Suzanne Cotter

Dengue Prevention in Asia

Overview of vaccination programme in Malta

Meningococcal Disease: Optimizing Protection in Adolescents

HPV-Related Disease: Separating Fact From Fiction

Global Update on Varicella: Protecting Against an Old Enemy

Adult Immunization: Making the Most of Everyday Opportunities

Pertussis disease: regional perspectives

Immunizing the Older Adult: Challenges and Opportunities

ACIP Recommended Vaccines for Adults – By Age

Immunization Against Varicella:

Improving Narcolepsy Diagnosis

The State of Pneumococcal Disease Prevention

Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs

Meningococcal Meningitis

Immunization FaQs 2018 Amy Bachyrycz.

Maternal Pertussis vaccination: Giving Newborns a head start

Serogroup B Meningococcal Disease

Number of catch-up doses needed (n = 200) at admission and at 1-month follow-up by vaccine type among 95 children found to be underimmunized per ACIP guidelines.

Preventing HPV-related Disease: What Do the Latest Data Tell Us?

Preventing Meningococcal B Disease

Epidemiology of Meningococcal disease in Scotland

IBD Increases Risk for Vaccine-Preventable Diseases

Addressing Pneumococcal Disease in Latino Communities

Immunization Throughout the Life Course: What Is the Clinician's Role?

Student Affairs Committee

Update on Shingles.

Can we control all-cause meningococcal disease in Europe?

Daniel M. Musher, MD Mayo Clinic Proceedings

Meningococcal group C disease in Greece during 1993–2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians D.A.

Nurse Practitioners: At the Forefront of HPV-Related Disease Prevention.

Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study

Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational.

Clinical Microbiology and Infection

Many immigrants are susceptible to vaccine-preventable diseases upon arrival in Canada. Evidence indicates that 30%–50% of new immigrants are susceptible.

Distilling the Data: The Latest Updates on HPV-Related Disease and Its Prevention.

Bacterial/Viral Meningitis & Haemophilus influenzae Trends in Ireland

Number of 2019–2020 seasonal influenza vaccine doses for children based on age and previous vaccination history and recommendations for prevention and.

MenB Update: Communicating the Imperative With Parents

Immunization in the Era of Health Reform: What’s Next?

Karen A. Cullen, Diana L. Bartlett, C. Robinette Curtis

Observations from the Well: ALERT IIS Data and HPV

Presentation transcript:

Meningococcal B Vaccination Implementing the ACIP Category B Recommendations

Meningococcal Disease Much Feared, Infrequently Seen

Burden of Disease

Invasive Meningococcal Disease by Year

ACIP Meningococcal B Category A Vaccination Recommendation

Incidence by Serogroup and Age Group United States, 2005-2013

US Universal Meningococcal Vaccine Program

ACIP Meningococcal B Category B Vaccination Recommendation

ACIP Meningococcal B Category A Vaccination Recommendation

ACIP Meningococcal B Category B Vaccination Recommendation

Rationale for Category B Recommendation

Why the Meningococcal B Category B Recommendation May Evolve

Implementing the Meningococcal B Category B Recommendation Children’s Minnesota

Discussion is Central

Why No Specific ACIP Guidance?

Abbreviations